Menu
Menu
From the town of Isafjordur in northwest Iceland, Kerecis develops, manufactures, and sells patented fish-skin soft tissue regeneration products that have regulatory approval in the United States, Europe and several other jurisdictions. We provide our customers with innovative digital tools for managing their business that include the use artificial intelligence (AI) to support insurance billing.
We have regional headquarters in the United States, Iceland, and Germany with 500 employees including a 200+ person direct US salesforce.
Kerecis is incorporated in Iceland and is privately owned by about 300 shareholders. The company is not listed on a public stock exchange. Several investment brokerages in Iceland from time-to-time support trade of shares. A list of investment brokerages in Iceland can be found on https://en.fme.is/supervision/supervised-entities
For information contact ir@kerecis.com
Kerecis has been well received on the market and sales have more than doubled year on year since its commercialization in 2015. In addition, the company has also shown low CapEX requirements and a strong gross margin.
Kerecis now has three main product lines on the market that are primarily sold by the company’s direct sales force in these care-settings:
Kerecis products utilize multiple patented fatty-acid technologies to protect and regenerate tissue. Our core technology is the Kerecis Omega3 Fish Skin.
Kerecis products categorize as medical devices and go through a rigorous process to be approved and commercialized in countries around the world. Furthermore, the Kerecis technology is patented in the United States and in more than 40 other countries.
We at Kerecis create tremendous value from a small amount of waste, and the benefits are far-reaching and often immeasurable. Our innovation in Iceland and operations worldwide allow doctors to heal patients, to benefit of families, friends, and entire communities. Therefore, everyone has a vested interest in sustaining our value creation and the factors that contribute to it.
We operate our production in the Westfjords, an area in the Arctic known for its commitment to environmental protection. As a leading employer in the town of Ísafjörður, we create life-saving value from waste by producing medical devices from locally procured, certified, sustainably sourced fish. Moreover, our manufacturing requires no harsh chemicals that might harm the environment, and it uses exclusively clean, renewable energy.
For further information, please contact Kerecis Investor Relations via email ir@kerecis.com
© 2010-2022 Kerecis. All Rights Reserved
